As of February 2017, there were 106 artificial intelligence startups in healthcare, according to a CB Insights report, and 70 of them launched last year.
Here are 13 healthcare AI startups that have raised $25 million or more, listed along with their investors.
Flatiron Health (New York City): $313 million. Flatiron's platform connects community practices and cancer centers on a common technology infrastructure to address healthcare challenges with the goal of powering a national benchmarking and research network for cancer care. The company provides its platform to more than 265 community cancer clinics and three major academic research centers.
Investors: Allen & Company, Baillie Gifford & Co., Casdin Capital, Google Ventures, Roche Venture Fund
Welltok (Denver): $238.62 million. Welltok's CafeWell Health Optimization Platform is designed to connect consumers with benefits, resources and rewards for personalized healthcare plans. The software-as-a-service company leverages advanced analytics for customer engagement and can provide information to payers, employers and government programs.
Investors: Bessemer Venture Partners, Catholic Health Initiatives, EDBI, Emergence Capital Partners, Flare Capital Partners, Georgia Partners, Hearst Venture, IBM Watson Group, InterWest Partners, Miramar Digital Ventures, Miramar Venture Partners, New Enterprise Associates, Okapi Venture Capital, Qualcomm Ventures, TriZetto Corp.
iCarbonX (China): $199 million. Founded in 2015, iCarobnX was designed to create a profile of individuals based on their biological, behavioral and psychological data using the internet and artificial intelligence. The technology provides individual health analysis and health index predictions through advanced data mining and machine analysis technologies.
Investors: China Bridge Capital, Tencent, Vcanbio
benevolent.ai (London): $140.55 million. BenevolentAI includes the company's technology arm in the bioscience industry — BenevolentBio — and the advanced artificial intelligence platform BenevolentTech designed to help scientists make new discoveries in healthcare and use data to drive innovation.
Investors: (N/A)
Butterfly Network (New York City): $100 Million. Butterfly Network is focused on building an ultrasound device that makes imaging accessible around the world. The technology includes all components of the ultrasound machine compacted into a silicon chip coupled with deep learning algorithms to guide less experienced clinicians on interpreting the findings.
Investors: Aeris Capital, Stanford University
Ayasdi (Menlo Park, Calif.): $97.8 million. Ayasdi includes clinical variation management and denials management solutions in its healthcare platform. The company's software application is designed to help providers detect clinical trends and develop best practices based on data from EMRs, which helps hospitals and health systems manage global episodes of care.
Investors: Centerview Capital, CitiVentures, Draper Nexus Ventures, Floodgate, Institutional Venture Partners, Khosla Ventures, Kleiner Perkins Caufield & Byers
Digital Reasoning (Franklin, Tenn.): $75.63 million. Digital Reasoning is a cognitive computing company focused on building software to bridge human communication. The company's Synthesys platform rapidly reads data and identifies if it is valuable or not. In healthcare, the technology can compile information about patients to build a complete picture of their issues.
Investors: Goldman Sachs, HCA, Health Evolution Partners, Lemhi Ventures, NASDAQ, Silver Lake
Apixio (San Mateo, Calif.): $45.36 million. The company's software-as-a-system application is designed to increase Medicare Advantage risk adjustment accuracy, productivity and speed. The application includes comprehensive chart analysis, a HIPAA-compliant cloud application and a robust performance dashboard.
Investors: Bain Capital Ventures, First Analysis, SSM Partners, Undisclosed Angel Investors
Pathway Genomics (San Diego): $40 million. Pathway's soon-to-launch mobile app, OME, combines the company's AI technology and IBM Watson to compile evidence-based health and wellness knowledge and deliver customized recommendations for general health issues. The database includes information from test results, genetics, health records, wearables and other information.
Investors: Edelson Technology Partners, Founders Fund, IBM Watson Group
H2O.ai (Mountainview, Calif.): $33.6 million. H20 is an open source deep learning platform that more than 80,000 data scientists use around the world. H20.ai is designed to develop mission critical data products for companies and can help data scientists in healthcare develop metrics and thresholds for treating patients.
Investors: Capital One Growth Ventures, Nexus Venture Partners, Paxion Capital Partners, Transamerica Ventures
Zephyr Health: $32.5 million (San Francisco). Companies such as Stryker and Genentech use Zephyr Health to gather data and identify insights into key trends. The company works with biopharmaceutical, medical device and diagnostic companies to connect treatments and therapies to patients who need them.
Investors: Google Ventures, Icon Ventures, Kleiner Perkins Caufield & Byers, Susa Ventures
Ginger.io (San Francisco): $28.22 million. Ginger.io's platform connects individuals with the guidance, support, therapy and medication needed to maintain a healthy lifestyle. The application connects people with professional coaches, licensed therapists and psychiatrists through mobile devices.
Investors: Ari Buchler, Bill Warner, ENIAC Ventures, James Joaquin, Kaiser Permanente Ventures, Kapor Capital, Khosla Ventures, LaunchCapital, Romulus Capital, Techstars, True Ventures, Ty Curry, Walt Winshall
Babylon Health (United Kingdom): $25 million. Babylon is a digital healthcare service that combines scientists, clinicians, mathematicians and engineers to develop medical expertise for users. The users can contact a physician or mental health expert through Babylon Health's application and receive healthcare advice.
Investors: DeepMind Technologies, Hoxton Ventures, Innocent Drinks, Kinnevik